View Item 

Show simple item record

Effect of Catheter Ablation on Progression of Paroxysmal Atrial Fibrillation

dc.contributor.authorJongnarangsin, Kriten_US
dc.contributor.authorSuwanagool, Arisaraen_US
dc.contributor.authorChugh, Amanen_US
dc.contributor.authorCrawford, Thomasen_US
dc.contributor.authorGood, Eric D.en_US
dc.contributor.authorPelosi, Frank Jr.en_US
dc.contributor.authorBogun, Frank M.en_US
dc.contributor.authorOral, Hakanen_US
dc.contributor.authorMorady, Freden_US
dc.date.accessioned2012-03-16T15:56:09Z
dc.date.available2013-03-04T15:29:55Zen_US
dc.date.issued2012-01en_US
dc.identifier.citationJongnarangsin, Krit ; Suwanagool, Arisara ; Chugh, Aman ; Crawford, Thomas ; Good, Eric ; Pelosi, Frank ; Bogun, Frank ; Oral, Hakan ; Morady, Fred (2012). "Effect of Catheter Ablation on Progression of Paroxysmal Atrial Fibrillation." Journal of Cardiovascular Electrophysiology 23(1). <http://hdl.handle.net/2027.42/90181>en_US
dc.identifier.issn1045-3873en_US
dc.identifier.issn1540-8167en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90181
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Incen_US
dc.subject.otherRadiofrequency Catheter Ablationen_US
dc.subject.otherHeart Failureen_US
dc.subject.otherAtrial Fibrillationen_US
dc.subject.otherAntiarrhythmic Drugsen_US
dc.titleEffect of Catheter Ablation on Progression of Paroxysmal Atrial Fibrillationen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbsecondlevelPhysiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, USAen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90181/1/j.1540-8167.2011.02137.x.pdf
dc.identifier.doi10.1111/j.1540-8167.2011.02137.xen_US
dc.identifier.sourceJournal of Cardiovascular Electrophysiologyen_US
dc.identifier.citedreferenceCalkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ: HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow‐up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2007; 4: 816 ‐ 861.en_US
dc.identifier.citedreferenceAllessie M, Ausma J, Schotten U: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230 ‐ 246.en_US
dc.identifier.citedreferenceAbe Y, Fukunami M, Yamada T, Ohmori M, Shimonagata T, Kumagai K, Kim J, Sanada S, Hori M, Hoki N: Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal‐averaged electrocardiography: A prospective study. Circulation 1997; 96: 2612 ‐ 2616.en_US
dc.identifier.citedreferenceEckstein J, Verheule S, de Groot NM, Allessie M, Schotten U: Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria. Prog Biophys Mol Biol 2008; 97: 435 ‐ 451.en_US
dc.identifier.citedreferenceBurstein B, Nattel S: Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802 ‐ 809.en_US
dc.identifier.citedreferenceFuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 651 ‐ 745.en_US
dc.identifier.citedreferenceWijffels MC, Kirchhof CJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954 ‐ 68.en_US
dc.identifier.citedreferenceAllessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL: Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 769 ‐ 777.en_US
dc.identifier.citedreferenceJahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, Packer DL, Hammill SC, Shen WK, Gersh BJ: Long‐term progression and outcomes with aging in patients with lone atrial fibrillation: A 30‐year follow‐up study. Circulation 2007; 115: 3050 ‐ 3056.en_US
dc.identifier.citedreferencede Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ: Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 55: 725 ‐ 731.en_US
dc.identifier.citedreferenceKerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, Sheldon R, Dorian P, Newman D: Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005; 149: 489 ‐ 496.en_US
dc.identifier.citedreferenceZaman AK, Fujii S, Sawa H, Goto D, Ishimori N, Watano K, Kaneko T, Furumoto T, Sugawara T, Sakuma I, Kitabatake A, Sobel BE: Angiotensin‐converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice. Circulation 2001; 103: 3123 ‐ 3128.en_US
dc.identifier.citedreferenceLee SH, Chen YC, Cheng CC, Higa S, Chen YJ, Chen SA: Hypertonicity increases rabbit atrium and pulmonary vein arrhythmogenesis: A potential contributor to the genesis of atrial fibrillation. Clin Exp Pharmacol Physiol 2009; 36: 419 ‐ 424.en_US
dc.identifier.citedreferencePretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RC, Marasco S, Medcalf RL, Ming Z, Head GA, Tan JW, Cemerlang N, Sadoshima J, Shioi T, Izumo S, Lukoshkova EV, Dart AM, Jennings GL, McMullen JR: Reduced phosphoinositide 3‐kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol 2009; 175: 998 ‐ 1009.en_US
dc.identifier.citedreferencePappone C, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Sacchi S, Mazzone P, Paglino G, Gulletta S, Sala S, Santinelli V: Atrial fibrillation progression and management: A 5‐year prospective follow‐up study. Heart Rhythm 2008; 5: 1501 ‐ 1507.en_US
dc.identifier.citedreferenceWatanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y: Metabolic syndrome and risk of development of atrial fibrillation: The Niigata preventive medicine study. Circulation 2008; 117: 1255 ‐ 1260.en_US
dc.identifier.citedreferenceKoide Y, Yotsukura M, Sakata K, Yoshino H, Ishikawa K: Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation. Clin Cardiol 2002; 25: 69 ‐ 75.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1540-8167.2011.02137.x.pdf
Size:
529.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.